Get the Weekly Intelligence Brief — top committee picks every Sunday.
PHG · NYSE · STOCK

Koninklijke Philips N.V.

Healthcare Updated August 11, 2026
$27.06
52W $23.85 – $33.44
61/100
$26.44B
20.1
0.92
AI Committee Verdict
Buy
61/100
Conviction: Moderate · 60% agreement · 5 analysts
Moderate

Is PHG Bullish or Bearish?

Bullish. Innellis AI committee rates Koninklijke Philips N.V. (PHG) Buy with a composite score of 61/100 , based on 5 analysts with 60% agreement. Last updated August 11, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +14.02 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -5.98 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.

Bull & Bear Case

Bull Case
  • Dividend yield of 4.2% pays you to wait — Value
  • EPS growing 157.8% YoY — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Revenue declining -25.8% YoY -- this is not a growth story right now — Growth
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 11, 2026
Overall Committee Score
61/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 39%
of 192 Healthcare peers
Value Analyst neutral
58 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Dividend yield of 4.2% pays you to wait
Growth Analyst neutral
50 / 100 · Moderate confidence
Moderate growth -- present but not remarkable
+ EPS growing 157.8% YoY
− Revenue declining -25.8% YoY -- this is not a growth story right now
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Macro Analyst bullish
78 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst bullish
62 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Technical Analysis

RSI (14)
64.1
Neutral
MACD Histogram
0.109
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Lh Ll
Support
$26.46
Resistance
$28.43
Bollinger %B
0.79
Inside Bands
Price vs Moving Averages
EMA 9
$26.62 Above
EMA 21
$26.57 Above
EMA 50
$26.70 Above
EMA 200
$27.25 Below

Fundamental Analysis

Valuation
91
Profitability
43
Financial Health
65
Cash Flow
70
Valuation
P/E Ratio 20.1×
P/B Ratio 1.97×
PEG Ratio 0.03
Dividend Yield 3.61%
52W High $33.44
52W Low $23.85
Quality & Growth
ROE 816.8%
ROA 332.2%
Gross Margin 4593.0%
Operating Margin 1016.8%
Revenue Growth YoY
Debt / Equity 0.65
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 20.1 (inexpensive relative to a 15-40x range); Price-to-book of 2.0x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 8.2%; Return on assets of 3.3%; Net margin of 6.3%; Gross margin of 45.9%; Current ratio of 1.26 (tight short-term liquidity); Debt-to-equity of 0.65; Free cash flow per share is positive (1.99); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full PHG Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore PHG Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime